investordatabase.org

Sofinnova Investments, INC.

sofinnova.com Direct investor

Sofinnova is a healthcare investment firm founded in 1976, focusing on life science investing, primarily in therapeutic drugs. It invests in private and public equity companies, with approximately $4.6B in assets under management.

Sofinnova Investments, INC. is a venture capital firm headquartered in Menlo Park, United States, founded in 1976. It invests directly in companies, from Series A to growth, in therapeutics, biotech and life sciences. $4.6B under management and 120 portfolio companies, as it reports.

“Sofinnova invests in late preclinical and clinical therapeutic companies across the U.S. and Europe.”

— Sofinnova Investments, INC., own website
Layer
Direct investor
Type
Venture capital
Stage
Series A – Growth
Headquarters
Menlo Park, United States
Invests in
US, Europe
Sectors
therapeutics, biotech, life sciences
Founded
1976
Assets under management
$4.6B
Portfolio
120 companies

Team, as Sofinnova Investments, INC. publishes it

  • Jim Healy Managing Partner
  • Maha Katabi General Partner
  • David Kabakoff Executive Advisor, Private Equity
  • Lars Ekman Executive Partner, Private Equity
  • Perry Nisen Executive Advisor, Private Equity
  • Jonathan Leff Executive Partner, Private Equity
  • Chris Carpenter Executive Partner, Private Equity
  • Jakob Dupont Executive Partner, Private Equity
  • Maha Radhakrishnan Executive Partner, Private Equity
  • Troy Ignelzi Executive Advisor, Private Equity
  • Mike Van Associate, Private Equity
  • Naomi Pacalin Associate, Private Equity

Names and roles exactly as listed on sofinnova.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 73 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

  • RA Capital Management 12 shared companies: ascendispharma.com, bioagelabs.com, aclaristx.com, coherus.com…
  • Avoro Capital Advisors LLC 7 shared companies: ascendispharma.com, apellis.com, merus.nl, amarincorp.com…
  • Aisling Capital Management LP 5 shared companies: ascendispharma.com, obseva.com, aclaristx.com, audentestx.com…
  • Foresite Capital 5 shared companies: ascendispharma.com, arrivent.com, aclaristx.com, audentestx.com…
  • Sofinnova 5 shared companies: ascendispharma.com, cincor.com, nucana.com, obseva.com…
  • Longitude Capital 5 shared companies: bioagelabs.com, inozyme.com, amarincorp.com, checkmatepharma.com…
  • OrbiMed 5 shared companies: bioagelabs.com, arrivent.com, star-therapeutics.com, avenzotx.com…
  • ARCH Venture Partners 5 shared companies: karunatx.com, mallinckrodt.com, citytx.com, rapportrx.com…
  • venBio Partners LLC 4 shared companies: apellis.com, aeovian.com, mareatx.com, rayzebio.com
  • Viking Global Investors LP 4 shared companies: star-therapeutics.com, rayzebio.com, atyrpharma.com, velosbio.com

and 63 more — the graph.

Where this comes from

Every fact above was read from a page Sofinnova Investments, INC. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4502 · added 2026-09-03 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under